Performance against the 62 day cancer target decreased with 59.0% of patients starting their first definitive treatment in the month within the target time.
Bu gostyngiad yn y perfformiad ar gyfer y targed canser 62 diwrnod gyda 59.0% o gleifion yn dechrau ar eu triniaeth ddiffiniol gyntaf yn ystod y mis o fewn yr amser targed.